Mr. Maurice J Williams, LCSW Counselor - Addiction (Substance Use Disorder) Medicare: Medicare Enrolled Practice Location: 15150 Alexandria St, Adelanto, CA 92301 Phone: 619-750-2292 |
Ms. Edna M Washington, BSHS Counselor - Addiction (Substance Use Disorder) Medicare: Not Enrolled in Medicare Practice Location: 11811 Cliffrose Ct, Adelanto, CA 92301 Phone: 760-246-4284 Fax: 760-244-8776 |
Michelle Garcia Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 11918 Chamberlaine Way, Adelanto, CA 92301 Phone: 760-412-9135 |
News Archive
In spite of an increased attention to gender differences in treatment of myocardial infarctions, focus on adherence to guidelines and a change in predominant therapy, the gender difference in treatment and mortality regarding the big infarctions - STEMI - has not diminished from 1998-2000 to 2004-2006. For some therapies, it has actually increased.
Molecular Detection Inc. (MDI), a company developing Detect-Ready assays designed to increase the speed and accuracy of infectious disease diagnosis, today announced that it has received a notice of allowance from the US Patent and Trademark Office (USPTO) for a patent application titled "Methods, Compositions and Kits for Detection and Analysis of Antibiotic Resistant Bacteria."
Shuo Ma, MD, '00 PhD, associate professor of Medicine in the Division of Hematology and Oncology, was co-first author of the clinical trial published in Blood.
Flavio de Pecol hit the trifecta after taking his daughter to the emergency room for a horse-riding injury: hours of waiting, a 16-mile ambulance ride to a different facility and bills for more than $40,000. At least, he thought, that was the end of it. But nearly two years (later), ... De Pecol, of Newport Beach, has received yet another bill, this time for $1,054.53. ... "How can I trust that this isn't a mistake when a hospital takes 21 months to bill me?" De Pecol asked. ... Good questions, and yet another example of the way consumers are at the mercy of the healthcare industry's opaque and byzantine billing practices (David Lazarus, 6/25).
ZIOPHARM Oncology, Inc. announced today the publication of a darinaparsin (Zinapar or ZIO-101) study in the PLoS ONE, an international, peer-reviewed, open-access, online publication of the Public Library of Science.
› Verified 7 days ago